Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome von Geethakumari, P R, Leiby, B, Nair, R, Alpdogan, S O, Carabasi, M, Filicko-O’Hara, J, Gaballa, S, Kasner, M, Klumpp, T, Martinez-Outschoorn, U, Palmisiano, N, Wagner, J L, Porcu, P, Flomenberg, N, Grosso, D

Volltext

Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment von Filicko, J, Lazarus, H M, Flomenberg, N

Volltext

Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization von Grosso, D, Johnson, E, Colombe, B, Alpdogan, O, Carabasi, M, Filicko-O'Hara, J, Gaballa, S, Kasner, M, Klumpp, T, Martinez-Outschoorn, U, Wagner, J L, Weiss, M, Wang, Z, Flomenberg, N

Volltext

P-038 Unbalanced translocation t(1;12)(q10;q10): A state of bone marrow insufficiency due to trisomy 1q? von Florea, A. Dulau, Filicko-O'Hara, J, Sprandio, J, Gong, J, Gulati, G, Besa, E, Bajaj, R

Volltext

Activity of single-agent melphalan 220-300 mg m with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma

Volltext

Adenovirus DNA polymerase is recognized by human CD8+ T cells von Joshi, Amita, Tang, Jie, Kuzma, Melanie, Wagner, John, Mookerjee, Bijoyesh, Filicko, Joanne, Carabasi, Matthew, Flomenberg, Neal, Flomenberg, Phyllis

Volltext

964PIMPACT OF BODY MASS INDEX ON OUTCOMES AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION von Tuazon, S.A., Palmisiano, N., Kakhniashvili, I., Keith, S., Dimou, A., Filicko-O'Hara, J.

Volltext

Impact of Body Mass Index on Outcomes After Autologous Hematopoietic Stem Cell Transplantation von Tuazon, S.A., Palmisiano, N., Kakhniashvili, I., Keith, S., Dimou, A., Filicko-O'Hara, J.

Volltext

Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: A phase I study von Phillips, G.L, Meisenberg, B, Reece, D.E, Adams, V.R, Badros, A, Brunner, J, Fenton, R, Filicko, J, Grosso, D, Hale, G.A, Howard, D.S, Johnson, V.P, Kniska, A, Marshall, K.W, Nath, R, Reed, E, Rapoport, A.P, Takebe, N, Vesole, D.H, Wagner, J.L, Flomenberg, N

Volltext

Update of melphalan 280 mg/m 2 plus amifostine cytoprotection before autologous stem cell transplantation as part of initial therapy in multiple myeloma patients von Reece, D. E., Flomenberg, N., Badros, A., Phillips, G. L., Filicko, J., Howard, D. S., Meisenberg, B., Rapoport, A., Vesole, D. H.

Volltext

Phase I trial of bortezomib, mitoxantrone and etoposide in relapsed/refractory acute leukemia von Filicko-O'Hara, J., Mookerjee, B., Carabasi, M. H., Besa, E., Wagner, J. L., Flomenberg, N.

Volltext

Cytoprotection in Acute Myelogenous Leukemia (AML) therapy von Grosso, Dolores, Filicko, Joanne, Garcia-Manero, Guillermo, Beardell, Frank, Brunner, Janet, Cohn, Jeffrey, Ferbér, Andres, Martinez, José, Mookerjee, Bijoyesh, Rose, Lewis, Tice, David, Wagner, John L., Capizzi, Robert, Flomenberg, Neal

Volltext

A 2 Step Approach to Myeloablative Haploidentical Hematopoietic Stem Cell Transplanation (HSCT): Report of a Phase II Trial With 18 Months of Follow-Up for All Patients von Grosso, D, Carabasi, M, Colombe, B, Cornett Farley, P, Flomenberg, P, Filicko-O'Hara, J, Kasner, M, O'Hara, W, Wagner, J.L, Weiss, M, Werner-Wasik, M, Flomenberg, N

Volltext

Sensorineural Hearing Loss Associated with Intrathecal Vancomycin von Klibanov, Olga M, Filicko, Joanne E, DeSimone, Joseph A, Jr, Tice, David S

Volltext

HLA Disparity and Rapid Immune Reconstitution Do Not Overcome Propensity to Relapse in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant (HSCT) With Persistent... von Grosso, D, Alpdogan, O, Carabasi, M, Colombe, B, Cornett Farley, P, Filicko-O'Hara, J, Flomenberg, P, Gitelson, E, Kasner, M, Martinez-Outschoorn, U, O'Hara, W, Wagner, J.L, Weiss, M, Werner-Wasik, M, Flomenberg, N

Volltext

Heterogeneous Clearance of Antithymocyte Globulin after CD34 +-Selected Allogeneic Hematopoietic Progenitor Cell Transplantation von Kakhniashvili, Irina, Filicko, Joanne, Kraft, Walter K., Flomenberg, Neal

Volltext

Activity of single-agent melphalan 220–300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma: Cytoreduction Re... von Phillips, G L, Meisenberg, B R, Reece, D E, Adams, V R, Badros, A Z, Brunner, J L, Fenton, R G, Filicko, J, Grosso, D L, Hale, G A, Howard, D S, Johnson, V P, Kniska, A, Marshall, K W, Mookerjee, B, Nath, R, Rapoport, A P, Sarkodee-Adoo, C, Takebe, N, Vesole, D H, Wagner, J L, Flomenberg, N

Volltext

135: A Two Step Approach to Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Patients with Hematologic Disorders von Grosso, D, Brunner, J, Carabasi, M, Dessain, S, Filicko-O'Hara, J, Mookerjee, B, O'Hara, W, Tedesco, N, Wagner, J.L, Flomenberg, N

Volltext

Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma von PHILLIPS, G. L, MEISENBERG, B. R, HOWARD, D. S, JOHNSON, V. P, KNISKA, A, MARSHALL, K. W, MOOKERJEE, B, NATH, R, RAPOPORT, A. P, SARKODEE-ADOO, C, TAKEBE, N, VESOLE, D. H, REECE, D. E, WAGNER, J. L, FLOMENBERG, N, ADAMS, V. R, BADROS, A. Z, BRUNNER, J. L, FENTON, R. G, FILICKO, J, GROSSO, D. L, HALE, G. A

Volltext

Amifostine does not protect against liver toxicity in patients receiving dose-escalated IV busulfan (IVBU) and standard dose cyclophosphamide in auto BMT von Grosso, D., Brunner, J., Dessain, S., Ferber, A., Filicko, J., Mookerjee, B., Shaw, L., Tedesco, N., Tran, H., Wagner, J., Flomenberg, N.

Volltext